期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | JOURNAL OF CLINICAL PHARMACOLOGY LetPub Score 6.3
50 ratings
Rate
Reputation 7.6 Influence 5.1 Speed 7.0 | ||||||||||||||||||||
期刊簡稱 | J CLIN PHARMACOL | ||||||||||||||||||||
ISSN | 1552-4604 | ||||||||||||||||||||
h-index | 104 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 4.20%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1552-4604 | ||||||||||||||||||||
在線稿件提交 | https://mc.manuscriptcentral.com/jocp | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Wiley-Blackwell | ||||||||||||||||||||
主題領域 | PHARMACOLOGY & PHARMACY | ||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||
發行頻率 | |||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||
每年文章數 | 165每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 23.86% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1552-4604%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: | ||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[JOURNAL OF CLINICAL PHARMACOLOGY] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 23:14:04 評論於 Just accept the editor's changes if you agree with them. If you disagree, simply write your reasons below the comments and give feedback to the editor. If both parties disagree, then negotiate(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 09:31:12 評論於 All questions must be answered separately, do not omit any; try to fulfill the experimental requirements in the comments, provide reasonable reasons if unable to meet the requirements that cannot be done; make sure to cite the literature recommended by the reviewers and discuss thoroughly; when submitting the revised manuscript, make sure to check the corrections made in the initial draft(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 龙鳞孝礼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 13:57:30 評論於 How to respond to reviewer comments?(0) 讚! | 龙鳞孝礼 |
作者: 八坂篷蔚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 15:23:20 評論於 How to respond to comments from journal editors?(0) 讚! | 八坂篷蔚 |
作者: 小希彤吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-12 18:46:33 評論於 How long does it take to go from an online (no journal) to a journal with volume and issue or print?(0) 讚! | 小希彤吖 |
作者: 大力彩霞 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-03-15 14:40:52 評論於 Do you need a layout fee? How much? Thank you(0) 讚! | 大力彩霞 |
作者: 留云志敏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-09-01 12:06:48 評論於 Hello, does this magazine charge for advertising space?(0) 讚! | 留云志敏 |
作者: 晓易小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-03-24 19:55:58 評論於 Review Speed: 1.0 Experience Sharing: The Journal of Clinical Pharmacology was submitted and accepted within 40 days, with one major revision and one minor revision in between. Submitted on 2.15, the status remained as "awaiting reviewers assign" until 3.23. After receiving an email, major revision was done on 3.24 and minor revision on 3.26. Overall, the process was quite efficient(0) 讚! | 晓易小公主 |
作者: 终幕翰采 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-11-24 20:14:43 評論於 Is this magazine indexed in SCI?(0) 讚! | 终幕翰采 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-18 08:15:31 評論於 Everything can only hope for next year, after all, there is no need to worry if the overall trend is upward. Even if it only rises a little bit in one year, it will accumulate over time, which is also good(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-11-28 15:27:24 評論於 Can we make it to top 3 next year? Let's discuss(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us